Medtronic (NYSE:MDT) said today it launched its Nuro system designed for treating overactive bladder with symptoms of urinary urgency, urinary frequency and urge incontinence. The Fridley, Minn.-based company said the device is designed to deliver percutaneous tibial neuromodulation treatment, a minimally invasive office-based procedure which provides a “measurable reduction” in urinary frequency or urinary incontinence. “Many people with […]
Urology
Intuitive Surgical touts cost study on robot-assisted prostate surgery
Intuitive Surgical (NSDQ:ISRG) is touting a study comparing the cost of prostate surgery using its da Vinci robot-assisted surgery device with traditional open surgery. The study, published in the journal Value in Health, assessed hospital costs, payers’ expenditures and societal expenses related to each procedure. The results showed that the robot-assisted surgery delivered shorter hospital stays, lower […]
NeoTract launches MedLift trial
NeoTract said Monday it enrolled the 1st patient in its MedLift U.S. investigational device exemption trial of its UroLift system for treating patients with benign prostatic hyperplasia. The new study from Pleasanton, Calif.-based NeoTract will be conducted across 8 sites in the U.S. and will examine the safety and efficacy of the UroLift system for […]
Boston Scientific releases ureteral stent tracker app
Boston Scientific (NYSE:BSX) has launched a new app designed to help urologists track ureteral stents implanted in patients with kidney stones. The app was developed as a joint operation between the Marlborough, Mass.-based medical device company and digital healthcare tool developer Visible Health, according to the company’s website. The tracker is designed to address issues with retained […]
Urologix sold to settle debt to Medtronic
Urologix Inc. (OCT:ULGX) yesterday said it sold almost all of its assets to a secured creditor, which then sold them to a private company that will operate the business as Urologix LLC. The remnants of Urologix Inc. were renamed 21st North Inc. The Minneapolis-based company, which makes the Cooled ThermoTherapy and Prostiva RF devices to treat benign […]
SRS Medical wins FDA nod for expanded study of Spanner prostate stent
SRS Medical Systems said it won the FDA’s approval for a clinical trial of its Spanner prostate stent for an expanded indication, a temporary implant designed to replace indwelling and intermittent urinary catheters. The Spanner device consists of a pair of anchors and a silicone tube and is designed to reduce resistance in the bladder neck and […]
Comfort Medical acquires Medical Direct Club
Urological device supplier Comfort Medical said yesterday it acquired direct-to-consumer urological supplier Medical Direct Club. Medical Direct Club is the 3rd largest direct-to-consumer supplier of urological catheters and supplies in the U.S., Coral Springs, Fla.-based Comfort Medical said. “Comfort has built an efficient and scalable patient-centric platform designed to provide its patients with unparalleled customer […]
Procept BioRobotics launches AquaBeam trial
Procept BioRobotics said today it treated the 1st patients in a clinical trial of its AquaBeam water ablation therapy system designed to treat prostate disease. The Water study is a phase III clinical study evaluating the safety and effectiveness of the system compared to transurethral resection of the prostate, the current standard of care for […]
Boston Scientific leads $40m round for NxThera
NxThera said today that Boston Scientific (NYSE:BSX) led a $40 million funding round for its Rezūm device, saying it plans to boost its sales footprint in the U.S. and Europe. Existing backers Aberdare Ventures, Arboretum Ventures, GDN Holdings and The Ally Bridge Group also participated, Maple Grove, Minn.-based NxThera said. The company said it also expanded a […]
Edap slips shareholders lawsuit
Edap (NSDQ:EDAP) said yesterday that the appeal deadline lapsed for a shareholders lawsuit filed after an FDA advisory panel recommended against approval for its its Ablatherm device for treating prostate cancer. EDAP shares plunged last year after the FDA’s Gastroenterology & Urology Devices panel voted that the device did not appear to be effective or safe. Ablatherm, which won […]
FDA clears Edap’s Ablatherm prostate device
Edap (NSDQ:EDAP) said today that it won 510(k) clearance from the FDA for its Ablatherm, less than a month after a similar device from rival SonaCare won a nod from the federal safety watchdog. The Ablatherm device, like SonaCare’s Sonablate 450, is designed to ablate prostate tissue using high-intensity focused ultrasound. After a years-long dance with the FDA that […]